Form 8-K - Current report:
SEC Accession No. 0001144204-15-023425
Filing Date
2015-04-17
Accepted
2015-04-17 09:00:20
Documents
19
Period of Report
2015-04-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v407529_8-k.htm 8-K 14708
2 EXHIBIT 99.1 v407529_ex99-1.htm EX-99.1 21081
3 GRAPHIC logo.jpg GRAPHIC 4758
4 GRAPHIC page01.jpg GRAPHIC 92480
5 GRAPHIC page02.jpg GRAPHIC 79811
6 GRAPHIC page03.jpg GRAPHIC 107752
7 GRAPHIC page04.jpg GRAPHIC 110679
8 GRAPHIC page05.jpg GRAPHIC 63451
9 GRAPHIC page06.jpg GRAPHIC 89694
10 GRAPHIC page07.jpg GRAPHIC 92304
11 GRAPHIC page08.jpg GRAPHIC 60980
12 GRAPHIC page09.jpg GRAPHIC 66705
13 GRAPHIC page10.jpg GRAPHIC 97866
14 GRAPHIC page11.jpg GRAPHIC 95944
15 GRAPHIC page12.jpg GRAPHIC 66403
16 GRAPHIC page13.jpg GRAPHIC 72851
17 GRAPHIC page14.jpg GRAPHIC 32329
18 GRAPHIC page15.jpg GRAPHIC 93569
19 GRAPHIC page16.jpg GRAPHIC 247329
  Complete submission text file 0001144204-15-023425.txt   2071371
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 15776609
SIC: 2834 Pharmaceutical Preparations